Alfa Chemistry Materials 5 - Products
Alfa Chemistry Materials is specialized in material chemistry and offers an extensive catalog of materials in a wide range of applications, including Metals and Materials, 3D Printing Materials, Biomaterials.
| Product | Description | |
|---|---|---|
| 4,7-Dimethyl-1,10-phenanthroline | 4,7-Dimethyl-1,10-phenanthroline. Group: Ligands for functional metal complexes. Alternative Names: 4,7-Dimethyl-o-phenanthroline. CAS No. 3248-5-3. Product ID: 4,7-dimethyl-1,10-phenanthroline. Molecular formula: 208.26. Mole weight: C14H12N2. CC1=C2C=CC3=C(C=CN=C3C2=NC=C1)C. JIVLDFFWTQYGSR-UHFFFAOYSA-N. InChI=1S/C14H12N2/c1-9-5-7-15-13-11 (9)3-4-12-10 (2)6-8-16-14 (12)13/h3-8H, 1-2H3. 98%. |  |
| 4,7-Phenanthroline | 4,7-Phenanthroline. Group: Ligands for functional metal complexes. Alternative Names: NCGC00246932-01; AKOS000267409; AC-907/25014296; DATYUTWESAKQQM-UHFFFAOYSA-N; CHEBI:36419; MLS000738107; SCHEMBL217044; AK306165; DTXSID30177552; F3099-7191. CAS No. 230-07-9. Product ID: 4,7-phenanthroline. Molecular formula: 180.21g/mol. Mole weight: C12H8N2. C1=CC2=C(C=CC3=C2C=CC=N3)N=C1. InChI=1S / C12H8N2 / c1-3-9-10-4-2-8-14-12 (10) 6-5-11 (9) 13-7-1 / h1-8H. DATYUTWESAKQQM-UHFFFAOYSA-N. | |
| 4,8-Bis[(2-ethylhexyl)oxy]-2,6-bis(trimethylstannyl)benzo[1,2-b:4,5-b']dithiophene | 4,8-Bis[(2-ethylhexyl)oxy]-2,6-bis(trimethylstannyl)benzo[1,2-b:4,5-b']dithiophene. Group: Small molecule semiconductor building blockspolymers. CAS No. 1160823-78-8. Product ID: [4,8-bis(2-ethylhexoxy)-2-trimethylstannylthieno[2,3-f][1]benzothiol-6-yl]-trimethylstannane. Molecular formula: 772.3g/mol. Mole weight: C32H54O2S2Sn2. CCCCC (CC)COC1=C2C=C (SC2=C (C3=C1SC (=C3)[Sn] (C) (C)C)OCC (CC)CCCC)[Sn] (C) (C)C. InChI=1S/C26H36O2S2. 6CH3. 2Sn/c1-5-9-11-19 (7-3)17-27-23-21-13-15-30-26 (21)24 (22-14-16-29-25 (22)23)28-18-20 (8-4)12-10-6-2; ; ; ; ; ; ; ; /h13-14, 19-20H, 5-12, 17-18H2, 1-4H3; 6*1H3;. XXMOZDBOAIICDA-UHFFFAOYSA-N. | |
| 4,8-Bis(2-ethylhexyloxy)benzo[1,2-b:4,5-b']dithiophene | 4,8-Bis(2-ethylhexyloxy)benzo[1,2-b:4,5-b']dithiophene. Group: Small molecule semiconductor building blockspolymerssemiconductor blocks. CAS No. 1160823-77-7. Product ID: 4,8-bis(2-ethylhexoxy)thieno[2,3-f][1]benzothiole. Molecular formula: 446.71. Mole weight: C26H38O2S2. CCCCC (CC)COC1=C2C=CSC2=C (C3=C1SC=C3)OCC (CC)CCCC. InChI=1S/C26H38O2S2/c1-5-9-11-19 (7-3)17-27-23-21-13-15-30-26 (21)24 (22-14-16-29-25 (22)23)28-18-20 (8-4)12-10-6-2/h13-16, 19-20H, 5-12, 17-18H2, 1-4H3. HATOWNJGYIVNBU-UHFFFAOYSA-N. >95.0%(HPLC). | |
| [4,8-Bis[5-(2-ethylhexyl)thieno[3,2-b]thiophen-2-yl]benzo[1,2-b:4,5-b']dithiophene-2,6-diyl]bis(trimethylstannane) | [4,8-Bis[5-(2-ethylhexyl)thieno[3,2-b]thiophen-2-yl]benzo[1,2-b:4,5-b']dithiophene-2,6-diyl]bis(trimethylstannane). Group: Small molecule semiconductor building blockspolymers. CAS No. 1444200-40-1. Product ID: [4,8-bis[2-(2-ethylhexyl)thieno[3,2-b]thiophen-5-yl]-2-trimethylstannylthieno[2,3-f][1]benzothiol-6-yl]-trimethylstannane. Molecular formula: 1016.8g/mol. Mole weight: C44H58S6Sn2. CCCCC (CC)CC1=CC2=C (S1)C=C (S2)C3=C4C=C (SC4=C (C5=C3SC (=C5)[Sn] (C) (C)C)C6=CC7=C (S6)C=C (S7)CC (CC)CCCC)[Sn] (C) (C)C. InChI=1S/C38H40S6. 6CH3. 2Sn/c1-5-9-11-23 (7-3)17-25-19-29-31 (41-25)21-33 (43-29)35-27-13-15-40-38 (27)36 (28-14-16-39-37 (28)35)34-22-32-30 (44-34)20-26 (42-32)18-24 (8-4)12-10-6-2; ; ; ; ; ; ; ; /h13-14, 19-24H, 5-12, 17-18H2, 1-4H3; 6*1H3;. OBJGKIDTANNASL-UHFFFAOYSA-N. | |
| 4,8-Bis[5-(2-ethylhexyl)thiophen-2-yl]-2,6-bis(trimethylstannyl)benzo[1,2-b:4,5-b']dithiophene | 4,8-Bis[5-(2-ethylhexyl)thiophen-2-yl]-2,6-bis(trimethylstannyl)benzo[1,2-b:4,5-b']dithiophene. Group: Small molecule semiconductor building blockspolymerssemiconductor blocks. CAS No. 1352642-37-5. Product ID: [4,8-bis[5-(2-ethylhexyl)thiophen-2-yl]-2-trimethylstannylthieno[2,3-f][1]benzothiol-6-yl]-trimethylstannane. Molecular formula: 904.56. Mole weight: C40H58S4Sn2. CCCCC (CC)CC1=CC=C (S1)C2=C3C=C (SC3=C (C4=C2SC (=C4)[Sn] (C) (C)C)C5=CC=C (S5)CC (CC)CCCC)[Sn] (C) (C)C. InChI=1S/C34H40S4. 6CH3. 2Sn/c1-5-9-11-23 (7-3)21-25-13-15-29 (37-25)31-27-17-19-36-34 (27)32 (28-18-20-35-33 (28)31)30-16-14-26 (38-30)22-24 (8-4)12-10-6-2; ; ; ; ; ; ; ; /h13-18, 23-24H, 5-12, 21-22H2, 1-4H3; 6*1H3;. OCFFMJYHZKHRKM-UHFFFAOYSA-N. >96.0%(HPLC). | |
| 4,8-Bis[5-(2-ethylhexyl)thiophen-2-yl]benzo[1,2-b:4,5-b']dithiophene | 4,8-Bis[5-(2-ethylhexyl)thiophen-2-yl]benzo[1,2-b:4,5-b']dithiophene. Group: Small molecule semiconductor building blockspolymers. CAS No. 1352642-35-3. Product ID: 4,8-bis[5-(2-ethylhexyl)thiophen-2-yl]thieno[2,3-f][1]benzothiole. Molecular formula: 579g/mol. Mole weight: C34H42S4. CCCCC (CC)CC1=CC=C (S1)C2=C3C=CSC3=C (C4=C2SC=C4)C5=CC=C (S5)CC (CC)CCCC. InChI=1S/C34H42S4/c1-5-9-11-23 (7-3)21-25-13-15-29 (37-25)31-27-17-19-36-34 (27)32 (28-18-20-35-33 (28)31)30-16-14-26 (38-30)22-24 (8-4)12-10-6-2/h13-20, 23-24H, 5-12, 21-22H2, 1-4H3. NNTCBLBIVSUXIW-UHFFFAOYSA-N. | |
| 4,8-Bis(dodecyloxy)benzo[1,2-b:4,5-b']dithiophene | 4,8-Bis(dodecyloxy)benzo[1,2-b:4,5-b']dithiophene. Group: Small molecule semiconductor building blockspolymers. CAS No. 1044795-04-1. Product ID: 4,8-didodecoxythieno[2,3-f][1]benzothiole. Molecular formula: 558.91999999999996. Mole weight: C34H54O2S2. CCCCCCCCCCCCOC1=C2C=CSC2=C (C3=C1SC=C3)OCCCCCCCCCCCC. InChI=1S / C34H54O2S2 / c1-3-5-7-9-11-13-15-17-19-21-25-35-31 -29-23-27-38-34 (29) 32 (30-24-28-37-33 (30) 31) 36-26-22-20-18-16-14-12-10-8-6-4-2 / h23-24, 27-28H, 3-22, 25-26H2, 1-2H3. BTJLOVWGQDIVHY-UHFFFAOYSA-N. >98.0%(HPLC). | |
| 4,8-Bis(n-octyloxy)-2,6-bis(trimethylstannyl)benzo[1,2-b:4,5-b']dithiophene | 4,8-Bis(n-octyloxy)-2,6-bis(trimethylstannyl)benzo[1,2-b:4,5-b']dithiophene. Group: Small molecule semiconductor building blockspolymerssemiconductor blocks. CAS No. 1098102-95-4. Product ID: (4,8-dioctoxy-2-trimethylstannylthieno[2,3-f][1]benzothiol-6-yl)-trimethylstannane. Molecular formula: 772.32. Mole weight: C32H54O2S2Sn2. CCCCCCCCOC1=C2C=C (SC2=C (C3=C1SC (=C3)[Sn] (C) (C)C)OCCCCCCCC)[Sn] (C) (C)C. InChI=1S / C26H36O2S2. 6CH3. 2Sn / c1-3-5-7-9-11-13-17-27-23-21-15-19-30 -26 (21) 24 (22-16-20-29-25 (22) 23) 28-18-14-12-10-8-6-4-2; ; ; ; ; ; ; ; / h15-16H, 3-14, 17-18H2, 1-2H3; 6 * 1H3;. CDHNVAGJGMNTLW-UHFFFAOYSA-N. >95.0%(HPLC). | |
| 4,8-Bis-n-octyloxybenzo[1,2-b:4,5-b']dithiophene | 4,8-Bis-n-octyloxybenzo[1,2-b:4,5-b']dithiophene. Group: Small molecule semiconductor building blocks. CAS No. 1098102-94-3. Product ID: 4,8-dioctoxythieno[2,3-f][1]benzothiole. Molecular formula: 446.7g/mol. Mole weight: C26H38O2S2. CCCCCCCCOC1=C2C=CSC2=C (C3=C1SC=C3)OCCCCCCCC. InChI= 1S / C26H38O2S2 / c1-3-5-7-9-11-13-17-27-23-21-15-19-30 -26 (21) 24 (22-16-20-29-25 (22) 23) 28-18-14-12-10-8-6-4-2 / h15-16, 19-20H, 3-14, 17-18H2, 1-2H3. LWSGUMOETOXOHL-UHFFFAOYSA-N. | |
| 4,8-Bis(n-octyloxy)benzo[1,2-b:4,5-b']dithiophene-2,6-dicarbaldehyde | 4,8-Bis(n-octyloxy)benzo[1,2-b:4,5-b']dithiophene-2,6-dicarbaldehyde. Group: Small molecule semiconductor building blockspolymerssemiconductor blocks. CAS No. 1668554-22-0. Product ID: 4,8-dioctoxythieno[2,3-f][1]benzothiole-2,6-dicarbaldehyde. Molecular formula: 502.7g/mol. Mole weight: C28H38O4S2. CCCCCCCCOC1=C2C=C (SC2=C (C3=C1SC (=C3)C=O)OCCCCCCCC)C=O. InChI=1S / C28H38O4S2 / c1-3-5-7-9-11-13-15-31-25-23-17-21 (19-29) 34-28 (23) 26 (24-18-22 (20-30) 33-27 (24) 25) 32-16-14-12-10-8-6-4-2 / h17-20H, 3-16H2, 1-2H3. JDPODAXHWNAIOO-UHFFFAOYSA-N. | |
| 4-(9H-Carbazol-9-yl)aniline | 4-(9H-Carbazol-9-yl)aniline. Group: Small molecule semiconductor building blocks. CAS No. 52708-37-9. Product ID: 4-carbazol-9-ylaniline. Molecular formula: 258.3g/mol. Mole weight: C18H14N2. C1=CC=C2C (=C1)C3=CC=CC=C3N2C4=CC=C (C=C4)N. InChI=1S/C18H14N2/c19-13-9-11-14 (12-10-13)20-17-7-3-1-5-15 (17)16-6-2-4-8-18 (16)20/h1-12H, 19H2. DEVUXRBOPYDIDJ-UHFFFAOYSA-N. | |
| 4-(9H-Carbazol-9-yl)benzaldehyde | 4-(9H-Carbazol-9-yl)benzaldehyde. Group: Small molecule semiconductor building blocks. CAS No. 110677-45-7. Product ID: 4-carbazol-9-ylbenzaldehyde. Molecular formula: 271.3g/mol. Mole weight: C19H13NO. C1=CC=C2C (=C1)C3=CC=CC=C3N2C4=CC=C (C=C4)C=O. InChI=1S/C19H13NO/c21-13-14-9-11-15 (12-10-14)20-18-7-3-1-5-16 (18)17-6-2-4-8-19 (17)20/h1-13H. RPHLDCKUUAGNAC-UHFFFAOYSA-N. | |
| 4-(9H-Carbazol-9-yl)phenylboronic Acid (contains varying amounts of Anhydride) | 4-(9H-Carbazol-9-yl)phenylboronic Acid (contains varying amounts of Anhydride). Group: Small molecule semiconductor building blocks. Alternative Names: 4-(9H-Carbazol-9-yl)benzeneboronic Acid (contains varying amounts of Anhydride). CAS No. 419536-33-7. Product ID: (4-carbazol-9-ylphenyl)boronic acid. Molecular formula: 287.13. Mole weight: C18H14BNO2. B (C1=CC=C (C=C1)N2C3=CC=CC=C3C4=CC=CC=C42) (O)O. InChI=1S/C18H14BNO2/c21-19 (22)13-9-11-14 (12-10-13)20-17-7-3-1-5-15 (17)16-6-2-4-8-18 (16)20/h1-12, 21-22H. JGAVTCVHDMOQTJ-UHFFFAOYSA-N. | |
| 4-Acetylbiphenyl | 4-Acetylbiphenyl. Group: Liquid crystal (lc) building blocks other electronic materials. CAS No. 92-91-1. Product ID: 1-(4-phenylphenyl)ethanone. Molecular formula: 196.24g/mol. Mole weight: C14H12O. CC(=O)C1=CC=C(C=C1)C2=CC=CC=C2. InChI=1S/C14H12O/c1-11 (15)12-7-9-14 (10-8-12)13-5-3-2-4-6-13/h2-10H, 1H3. QCZZSANNLWPGEA-UHFFFAOYSA-N. | |
| 4-Acetylphenylboronic Acid (contains varying amounts of Anhydride) | 4-Acetylphenylboronic Acid (contains varying amounts of Anhydride). Group: Liquid crystal (lc) building blocks. Alternative Names: 4-Acetylbenzeneboronic Acid (contains varying amounts of Anhydride). CAS No. 149104-90-5. Product ID: (4-acetylphenyl)boronic acid. Molecular formula: 163.97. Mole weight: C8H9BO3. B(C1=CC=C(C=C1)C(=O)C)(O)O. InChI=1S/C8H9BO3/c1-6 (10)7-2-4-8 (5-3-7)9 (11)12/h2-5, 11-12H, 1H3. OBQRODBYVNIZJU-UHFFFAOYSA-N. | |
| 4-Amino-2,1,3-benzothiadiazole | 4-Amino-2,1,3-benzothiadiazole. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 767-64-6. Product ID: 2,1,3-benzothiadiazol-4-amine. Molecular formula: 151.19g/mol. Mole weight: C6H5N3S. C1=CC2=NSN=C2C(=C1)N. InChI=1S/C6H5N3S/c7-4-2-1-3-5-6 (4)9-10-8-5/h1-3H, 7H2. DRLGIZIAMHIQHL-UHFFFAOYSA-N. | |
| 4-Amino-2,2,6,6-tetramethylpiperidine 1-Oxyl Free Radical | 4-Amino-2,2,6,6-tetramethylpiperidine 1-Oxyl Free Radical. Group: Organic radicalsbattery materials electronic materials polymerization reagents. CAS No. 14691-88-4. Molecular formula: 171.26g/mol. Mole weight: C9H19N2O. CC1(CC(CC(N1[O])(C)C)N)C. InChI=1S/C9H19N2O/c1-8 (2)5-7 (10)6-9 (3, 4)11 (8)12/h7H, 5-6, 10H2, 1-4H3. XUXUHDYTLNCYQQ-UHFFFAOYSA-N. | |
| 4-Amino-2,2,6,6-tetramethylpiperidine 1-Oxyl Free Radical (purified by sublimation) | 4-Amino-2,2,6,6-tetramethylpiperidine 1-Oxyl Free Radical (purified by sublimation). Group: Organic radicals other material building blocksbattery materials polymerization reagents. Alternative Names: 4-Amino-TEMPO Free Radical (purified by sublimation). CAS No. 14691-88-4. Molecular formula: 171.26. Mole weight: C9H19N2O. CC1(CC(CC(N1[O])(C)C)N)C. InChI=1S/C9H19N2O/c1-8 (2)5-7 (10)6-9 (3, 4)11 (8)12/h7H, 5-6, 10H2, 1-4H3. XUXUHDYTLNCYQQ-UHFFFAOYSA-N. >98.0%(GC). | |
| 4'-Aminobenzo-15-crown 5-Ether | 4'-Aminobenzo-15-crown 5-Ether. Group: Macrocyclessupramolecular host materials. CAS No. 60835-71-4. Product ID: 2,5,8,11,14-pentaoxabicyclo[13.4.0]nonadeca-1(15),16,18-trien-17-amine. Molecular formula: 283.32g/mol. Mole weight: C14H21NO5. C1COCCOC2=C(C=C(C=C2)N)OCCOCCO1. InChI=1S / C14H21NO5 / c15-12-1-2-13-14 (11-12) 20-10-8-18-6-4-16-3-5-17-7-9-19-13 / h1-2, 11H, 3-10, 15H2. CQNGAZMLFIMLQN-UHFFFAOYSA-N. | |
| 4-Aminobenzoic acid | 4-Aminobenzoic acid (also known as para-aminobenzoic acid or PABA because the number 4 carbon in the benzene ring is also known as the para position) is an organic compound with the formula H2NC6H4CO2H. PABA, a white-grey crystalline substance, is only slightly soluble in water. It consists of a benzene ring substituted with an amino group and a carboxyl group. Group: Liquid crystal (lc) building blocks. Alternative Names: 4-Aminobenzoic acid; PABA,Vitamin Bx,Vitamin H1; Benzoic acid, 4-amino-. CAS No. 150-13-0. Product ID: 4-aminobenzoic acid. Molecular formula: 137.14g/mol. Mole weight: C7H7NO2. C1=CC(=CC=C1C(=O)O)N. InChI=1S/C7H7NO2/c8-6-3-1-5 (2-4-6)7 (9)10/h1-4H, 8H2, (H, 9, 10). ALYNCZNDIQEVRV-UHFFFAOYSA-N. | |
| 4-Aminobenzonitrile | 4-Aminobenzonitrile. Group: Liquid crystal (lc) building blocks. CAS No. 873-74-5. Product ID: 4-aminobenzonitrile. Molecular formula: 118.14g/mol. Mole weight: C7H6N2. C1=CC(=CC=C1C#N)N. InChI=1S/C7H6N2/c8-5-6-1-3-7 (9)4-2-6/h1-4H, 9H2. YBAZINRZQSAIAY-UHFFFAOYSA-N. | |
| 4-Aminobutyric Acid Hydroiodide, ≥98% | 4-Aminobutyric Acid Hydroiodide, ≥98%. Group: Electronic chemicals. CAS No. 2096495-60-0. | |
| 4-Aminocyclohexanecarboxylic Acid (cis- and trans- mixture) | 4-Aminocyclohexanecarboxylic Acid (cis- and trans- mixture). Group: Liquid crystal (lc) building blocks. CAS No. 1776-53-0. Product ID: 4-aminocyclohexane-1-carboxylic acid. Molecular formula: 143.18g/mol. Mole weight: C7H13NO2. C1CC(CCC1C(=O)O)N. InChI=1S/C7H13NO2/c8-6-3-1-5 (2-4-6)7 (9)10/h5-6H, 1-4, 8H2, (H, 9, 10). DRNGLYHKYPNTEA-UHFFFAOYSA-N. | |
| 4-Aminocyclohexanecarboxylic Acid, (cis- and trans- mixture) | 4-Aminocyclohexanecarboxylic Acid, (cis- and trans- mixture). Group: Liquid crystal (lc) building blocks. CAS No. 1776-53-0. Product ID: 4-aminocyclohexane-1-carboxylic acid. Molecular formula: 143.18g/mol. Mole weight: C7H13NO2. C1CC(CCC1C(=O)O)N. InChI=1S/C7H13NO2/c8-6-3-1-5 (2-4-6)7 (9)10/h5-6H, 1-4, 8H2, (H, 9, 10). DRNGLYHKYPNTEA-UHFFFAOYSA-N. | |
| 4-(Aminomethyl)benzonitrile Hydrochloride, 97% | 4-(Aminomethyl)benzonitrile Hydrochloride, 97%. Group: other glass and ceramic materials. CAS No. 15996-76-6. Product ID: 4-(aminomethyl)benzonitrile; hydrochloride. Molecular formula: 168.62g/mol. Mole weight: C8H9ClN2. C1=CC(=CC=C1CN)C#N.Cl. InChI=1S/C8H8N2. ClH/c9-5-7-1-2-8(6-10)4-3-7; /h1-4H, 5, 9H2; 1H. QREZLLYPLRPULF-UHFFFAOYSA-N. | |
| 4-Aminophenol | P-aminophenol appears as white or reddish-yellow crystals or light brown powder. Turns violet when exposed to light. (NTP, 1992);DryPowder;Solid. Group: Liquid crystal (lc) building blocks. CAS No. 123-30-8. Product ID: 4-aminophenol. Molecular formula: 109.13g/mol. Mole weight: C6H7NO. C1=CC(=CC=C1N)O. InChI=1S/C6H7NO/c7-5-1-3-6 (8)4-2-5/h1-4, 8H, 7H2. PLIKAWJENQZMHA-UHFFFAOYSA-N. | |
| 4-Aminophthalonitrile | 4-Aminophthalonitrile. Group: Phthalonitriles & naphthalonitrilesphthalocyanine building blocks. CAS No. 56765-79-8. Product ID: 4-aminobenzene-1,2-dicarbonitrile. Molecular formula: 143.15g/mol. Mole weight: C8H5N3. C1=CC(=C(C=C1N)C#N)C#N. InChI=1S/C8H5N3/c9-4-6-1-2-8 (11)3-7 (6)5-10/h1-3H, 11H2. RRCAJFYQXKPXOJ-UHFFFAOYSA-N. | |
| 4-Aminopyrene | 4-Aminopyrene. Group: Small molecule semiconductor building blockselectroluminescence materials semiconductor blocks. CAS No. 17075-03-5. Product ID: pyren-4-amine. Molecular formula: 217.26g/mol. Mole weight: C16H11N. C1=CC2=C3C (=C1)C=C (C4=CC=CC (=C43)C=C2)N. InChI=1S / C16H11N / c17-14-9-12-5-1-3-10-7-8-11-4-2-6-13 (14) 16 (11) 15 (10) 12 / h1-9H, 17H2. AYBSKADMMKVOIV-UHFFFAOYSA-N. | |
| 4-Aminotriphenylamine | 4-Aminotriphenylamine. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 2350-1-8. Product ID: 4-N,4-N-diphenylbenzene-1,4-diamine. Molecular formula: 260.3g/mol. Mole weight: C18H16N2. C1=CC=C (C=C1)N (C2=CC=CC=C2)C3=CC=C (C=C3)N. InChI=1S/C18H16N2/c19-15-11-13-18 (14-12-15) 20 (16-7-3-1-4-8-16) 17-9-5-2-6-10-17/h1-14H, 19H2. UXKQNCDDHDBAPD-UHFFFAOYSA-N. | |
| 4-Amylaniline | 4-Amylaniline. Group: Liquid crystal (lc) building blocksliquid crystal (lc) materials. Alternative Names: 4-Pentylaniline. CAS No. 33228-44-3. Product ID: 4-pentylaniline. Molecular formula: 163.26. Mole weight: C11H17N. CCCCCC1=CC=C(C=C1)N. InChI=1S / C11H17N / c1-2-3-4-5-10-6-8-11 (12) 9-7-10 / h6-9H, 2-5, 12H2, 1H3. DGFTWBUZRHAHTH-UHFFFAOYSA-N. >97.0%(GC)(T). | |
| 4-Amylbenzoic Acid | 4-Amylbenzoic Acid. Group: Liquid crystal (lc) building blocks. CAS No. 26311-45-5. Product ID: 4-pentylbenzoic acid. Molecular formula: 192.25g/mol. Mole weight: C12H16O2. CCCCCC1=CC=C(C=C1)C(=O)O. InChI=1S / C12H16O2 / c1-2-3-4-5-10-6-8-11 (9-7-10) 12 (13) 14 / h6-9H, 2-5H2, 1H3, (H, 13, 14). CWYNKKGQJYAHQG-UHFFFAOYSA-N. | |
| 4-Amyloxybenzaldehyde | 4-Amyloxybenzaldehyde. Group: Liquid crystal (lc) building blocks. CAS No. 5736-91-4. Product ID: 4-pentoxybenzaldehyde. Molecular formula: 192.25g/mol. Mole weight: C12H16O2. CCCCCOC1=CC=C(C=C1)C=O. InChI=1S / C12H16O2 / c1-2-3-4-9-14-12-7-5-11 (10-13) 6-8-12 / h5-8, 10H, 2-4, 9H2, 1H3. YAPVGSXODFOBBR-UHFFFAOYSA-N. | |
| 4-Amyloxybenzoic Acid | 4-Amyloxybenzoic Acid. Group: Liquid crystal (lc) building blocksliquid crystal (lc) materials. CAS No. 15872-41-0. Product ID: 4-pentoxybenzoic acid. Molecular formula: 208.25g/mol. Mole weight: C12H16O3. CCCCCOC1=CC=C(C=C1)C(=O)O. InChI=1S / C12H16O3 / c1-2-3-4-9-15-11-7-5-10 (6-8-11) 12 (13) 14 / h5-8H, 2-4, 9H2, 1H3, (H, 13, 14). OZPPUPJQRJYTNY-UHFFFAOYSA-N. | |
| 4-Anilino-1,1':4',1''-terphenyl | 4-Anilino-1,1':4',1''-terphenyl. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 897671-81-7. Product ID: N-phenyl-4-(4-phenylphenyl)aniline. Molecular formula: 321.4g/mol. Mole weight: C24H19N. C1=CC=C (C=C1)C2=CC=C (C=C2)C3=CC=C (C=C3)NC4=CC=CC=C4. InChI=1S/C24H19N/c1-3-7-19 (8-4-1)20-11-13-21 (14-12-20)22-15-17-24 (18-16-22)25-23-9-5-2-6-10-23/h1-18, 25H. VWXSLLOSYCKNCF-UHFFFAOYSA-N. | |
| 4arm-PEG10K | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K 2arm-OH 2arm-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG 2arm-OH 2arm-COOH. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K 2arm-OH 2arm-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG 2arm-OH 2arm-NH2. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K 3arm-OH 1arm-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG 3arm-OH 1arm-COOH. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K 3arm-OH 1arm-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG 3arm-OH 1arm-NH2. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-COOH, 4arm-PEG-Carboxyl. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Glutaric Acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Glutaric Acid. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Isocyanate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Maleimide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-MAL, 4arm-PEG-Maleimide. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-NH2, 4arm-PEG-NH2. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-SH. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Ester, 4arm-PEG-SCM. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Succinimidyl Carboxymethyl Glutaramide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Glutaramide. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Succinimidyl Glutarate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Glutarate. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Succinimidyl Succinate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Succinate. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Vinylsulfone | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-VS, 4arm-PEG-Vinylsulfone. Molecular formula: average Mn 10000. | |
| 4arm-PEG20K 2arm-OH, 2arm-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 20000. | |
| 4arm-PEG20K 3arm-OH, 1arm-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-COOH, 4arm-PEG-Carboxyl. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-Isocyanate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Isocyanate. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-Maleimide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-MAL, 4arm-PEG-Maleimide. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-NH2, 4arm-PEG-amine. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-SH. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-Succinimidyl Carboxymethyl Glutaramide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Glutaramide. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-Succinimidyl Glutarate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Glutarate. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-Succinimidyl Succinate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Succinate. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-Vinylsulfone | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-VS, 4arm-PEG-Vinylsulfone. Molecular formula: average Mn 20000. | |
| 4arm-PEG2500-PCL2500 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-PCL. Molecular formula: PCL average Mn 2,500 PEG average Mn 2,500. | |
| 4arm-PEG2500-PLA3500 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-PLA. Molecular formula: PCL average Mn 3,500 PEG average Mn 2,500. | |
| 4arm-PEG2K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-NH2, 4arm-PEG-amine. Molecular formula: average Mn 2000. | |
| 4arm-PEG3K 3arm-OH, 1arm-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 3000. | |
| 4arm-PEG40K-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-COOH, 4arm-PEG-Carboxyl. Molecular formula: average Mn 40000. | |
| 4arm-PEG40K-Maleimide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-MAL, 4arm-PEG-Maleimide. Molecular formula: average Mn 40000. | |
| 4arm-PEG40K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-NH2, 4arm-PEG-amine. Molecular formula: average Mn 40000. | |
Would you like to list your products on USA Chemical Suppliers?
Our database is helping our users find suppliers everyday.